Equities
Health CareHealth Care Providers
  • Price (USD)227.46
  • Today's Change-3.21 / -1.39%
  • Shares traded1.23m
  • 1 Year change-40.49%
  • Beta0.4477
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.

  • Revenue in USD (TTM)120.26bn
  • Net income in USD1.71bn
  • Incorporated1964
  • Employees65.68k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.humana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HUM:NYQ since
announced
Transaction
value
Intrepid USA Healthcare ServicesDeal completed12 Aug 202412 Aug 2024Deal completed-35.17%--
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chemed Corp2.49bn308.74m6.73bn15.70k22.405.6718.092.7020.5320.53165.4781.091.44175.3710.75158,585.3017.8819.2021.4324.0534.8235.2012.4012.781.70--0.00048.197.374.6310.826.55-1.357.74
Ensign Group Inc4.42bn309.42m8.28bn39.30k27.174.3020.771.875.305.3075.7633.480.9756--8.02112,553.506.836.668.118.1121.3222.307.006.87----0.06975.6514.2415.9142.3026.58-5.784.78
Hims & Hers Health Inc1.78bn164.40m10.72bn1.64k70.0319.4957.376.010.68390.68397.402.462.667.73267.341,090,014.0024.54-3.9134.03-4.7477.04--9.21-2.351.32--0.00--69.33--635.28155.96----
Davita Inc12.97bn859.61m10.76bn76.00k14.11--5.690.829910.1010.10152.64-3.460.750759.125.28170,638.506.816.099.268.0632.4631.219.088.691.204.050.8544--5.562.3935.405.82-6.24--
Universal Health Services Inc16.08bn1.20bn11.76bn86.00k10.251.736.490.731317.8117.81239.04105.301.11--6.83187,024.108.436.6810.017.94----7.586.621.239.840.40315.6310.826.8259.177.047.565.92
Encompass Health Corp5.51bn494.00m11.96bn23.56k24.485.5212.392.174.844.8253.9921.440.8565--8.87233,941.6010.206.7213.268.3995.6095.4111.919.53--7.090.45726.0411.913.1326.024.949.72-10.27
Molina Healthcare Inc41.87bn1.18bn12.01bn18.00k10.702.788.800.286820.7020.70737.0879.812.62--12.242,325,889.007.377.3015.4415.9615.2215.662.812.86--12.810.46630.0019.3119.298.079.8511.90--
Centene Corp169.28bn3.45bn15.64bn60.50k4.680.56033.330.09246.726.72329.5556.112.00--8.622,798,083.004.072.796.934.4210.2711.272.041.48--5.260.39540.005.8916.9222.3220.13-2.48--
Tenet Healthcare Corp20.52bn1.46bn16.32bn74.48k11.623.905.150.795515.1215.12212.6045.010.70589.816.66275,510.208.096.3211.888.9882.3382.7511.468.841.706.080.60350.000.56942.26423.73--6.80--
Quest Diagnostics Inc10.16bn892.00m18.76bn45.00k21.382.7213.071.857.867.8689.5061.870.682936.717.45225,733.306.188.967.1310.4033.1536.159.0512.551.316.810.454125.686.705.021.880.73171.226.90
Labcorp Holdings Inc13.18bn730.80m20.89bn70.00k28.792.5213.251.598.678.67156.3699.130.772119.735.88188,248.604.296.165.217.3327.8932.185.559.171.605.480.404--6.972.4096.73-1.964.13--
Natera Inc1.83bn-189.76m21.91bn4.42k--17.59--11.96-1.47-1.4714.289.121.1414.986.03413,878.80-11.86-30.60-15.01-38.8261.7951.43-10.36-40.613.74--0.0609--56.7541.2056.20--72.97--
Humana Inc120.26bn1.71bn27.84bn65.68k16.311.5710.050.231514.1414.14996.52147.082.38----1,831,029.003.626.19--------1.522.69--5.470.427515.1110.7012.66-51.51-14.92-4.8210.49
Data as of Jul 14 2025. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD

Institutional shareholders

43.76%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202513.41m11.12%
Dodge & Coxas of 31 Mar 202510.76m8.92%
BlackRock Fund Advisorsas of 31 Mar 20256.61m5.48%
SSgA Funds Management, Inc.as of 31 Mar 20255.32m4.41%
Pzena Investment Management LLCas of 31 Mar 20253.83m3.17%
Eagle Capital Management LLCas of 31 Mar 20253.14m2.61%
Geode Capital Management LLCas of 31 Mar 20253.07m2.55%
Wellington Management Co. LLPas of 31 Mar 20252.39m1.98%
Davis Selected Advisers LPas of 31 Mar 20252.33m1.93%
JPMorgan Investment Management, Inc.as of 31 Mar 20251.92m1.59%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.